Results 271 to 280 of about 54,917 (299)

SGLT2 Inhibitors Decrease Cardiovascular Death and Heart Failure Hospitalizations in Patients With Heart Failure: A Systematic Review and Meta-Analysis

EClinicalMedicine, 2021
Deepak L. Bhatt, Rhanderson Cardoso, Gilson Fernandes   +2 more
exaly  

SGLT2 Inhibitors as the Bedrock of Therapy for Heart Failure

Lancet, The, 2022
Katherine R Tuttle
exaly  

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection.

JACC Basic To Translational Science, 2020
Vance B Matthews, Lakshini Herat, Marcio Kiuchi   +2 more
exaly  

SGLT2 Inhibition Mediates Protection From Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition

Cell Metabolism, 2020
Hisakazu Ogita, Shinji Kume, Kosuke Yamahara   +2 more
exaly  

The Impact of SGLT2 Inhibitors on Inflammation: A Systematic Review and Meta-Analysis of Studies in Rodents

International Immunopharmacology, 2022
Dimitris Tousoulis, Gerasimos Siasos, Evangelos Oikonomou   +2 more
exaly  

SGLT2 Inhibitors in Patients With Heart Failure: A Comprehensive Meta-Analysis of Five Randomised Controlled Trials

Lancet, The, 2022
exaly  

Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis

Frontiers in Pharmacology, 2022
Jolanta M Siller-Matula, Dirk von Lewinski, Zofia Agnieszka Wicik   +2 more
exaly  

Risk of Diabetic Ketoacidosis After Initiation of an SGLT2 Inhibitor

New England Journal of Medicine, 2017
Michael Fralick, Elisabetta Patorno, Sebastian Schneeweiss   +2 more
exaly  

SGLT2 inhibitors

Clinical Therapeutics, 2015
openaire   +1 more source

SGLT2 Inhibitors: Molecular Design and Potential Differences in Effect

Kidney International, 2011
Masayuki Isaji
exaly